BR112014005358A8 - Composições compreendendo agonista seletivo de trpv1 e seus usos - Google Patents
Composições compreendendo agonista seletivo de trpv1 e seus usosInfo
- Publication number
- BR112014005358A8 BR112014005358A8 BR112014005358A BR112014005358A BR112014005358A8 BR 112014005358 A8 BR112014005358 A8 BR 112014005358A8 BR 112014005358 A BR112014005358 A BR 112014005358A BR 112014005358 A BR112014005358 A BR 112014005358A BR 112014005358 A8 BR112014005358 A8 BR 112014005358A8
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- selective agonist
- trpv1
- trpv1 selective
- agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161533120P | 2011-09-09 | 2011-09-09 | |
| US201261642942P | 2012-05-04 | 2012-05-04 | |
| PCT/US2012/054511 WO2013036961A1 (en) | 2011-09-09 | 2012-09-10 | A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014005358A2 BR112014005358A2 (pt) | 2017-03-28 |
| BR112014005358A8 true BR112014005358A8 (pt) | 2017-10-03 |
Family
ID=46940596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014005358A BR112014005358A8 (pt) | 2011-09-09 | 2012-09-10 | Composições compreendendo agonista seletivo de trpv1 e seus usos |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US8889659B2 (https=) |
| EP (2) | EP3388057B1 (https=) |
| JP (1) | JP6228540B2 (https=) |
| KR (1) | KR101769010B1 (https=) |
| CN (1) | CN104010635A (https=) |
| BR (1) | BR112014005358A8 (https=) |
| CA (1) | CA2854206C (https=) |
| MX (1) | MX347902B (https=) |
| WO (1) | WO2013036961A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3388057B1 (en) * | 2011-09-09 | 2022-03-09 | Propella Therapeutics, Inc. | A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof |
| AU2013341380B2 (en) | 2012-11-12 | 2018-04-26 | Propella Therapeutics, Inc. | Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid |
| CN105848666A (zh) * | 2013-10-28 | 2016-08-10 | Atp研究有限公司 | 疼痛缓解制剂以及治疗方法 |
| US20160334391A1 (en) * | 2014-01-23 | 2016-11-17 | Biogaia Ab | Selection of Agents Modulating Gastrointestinal Pain |
| JP6580305B2 (ja) * | 2014-03-30 | 2019-09-25 | 小林製薬株式会社 | 外用医薬組成物 |
| JP6599083B2 (ja) * | 2014-03-30 | 2019-10-30 | 小林製薬株式会社 | 外用医薬組成物 |
| MX377377B (es) | 2014-04-15 | 2025-03-10 | Propella Therapeutics Inc | Composiciones tópicas para el alivio del dolor, manufactura y uso. |
| KR102413721B1 (ko) * | 2014-11-26 | 2022-06-27 | 건양대학교산학협력단 | 통증완화 성분이 포함된 알코올성 조성물, 및 이를 포함하는 알코올 스왑 |
| JP6508671B2 (ja) * | 2015-01-30 | 2019-05-08 | ハウスウェルネスフーズ株式会社 | トウガラシ抽出物及び／又はショウガ抽出物を含む組成物、ならびにその製造方法 |
| WO2017020125A1 (en) | 2015-07-31 | 2017-02-09 | Delivra Inc. | Transdermal formulations for delivery of capsaicinoids |
| FR3039991A1 (fr) * | 2015-08-12 | 2017-02-17 | Ab7 Innovation | Composition antidouleur comprenant un derive de l'acide salicylique |
| JP6948762B2 (ja) * | 2015-10-16 | 2021-10-13 | 株式会社マンダム | Ｔｒｐｖ１活性抑制剤作用増幅用組成物 |
| EP3405187A4 (en) * | 2016-01-22 | 2019-07-31 | Centrexion Therapeutics Corporation | SEQUENCING DOSAGE METHOD FOR CAPSAICN FOR THE TREATMENT OF MORTON NEUROM |
| KR102657458B1 (ko) | 2016-11-02 | 2024-04-12 | 센트렉시온 테라퓨틱스 코포레이션 | 안정한 수성의 캡사이신 주사 가능한 제형 및 이의 의학적 용도 |
| PT3534922T (pt) | 2016-11-04 | 2024-06-07 | Takeda Pharmaceuticals Co | Formulações de vírus adenoassociado |
| TWI776879B (zh) * | 2017-04-04 | 2022-09-11 | 日商花王股份有限公司 | 身體化妝料 |
| WO2018198029A1 (en) * | 2017-04-25 | 2018-11-01 | Azista Industries Pvt Ltd | Matrix adhesive patch and process for the preparation thereof |
| WO2019018769A1 (en) | 2017-07-20 | 2019-01-24 | Centrexion Therapeutics Corporation | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN USING CAPSAICINE |
| AU2019299964A1 (en) | 2018-07-11 | 2021-01-21 | Takeda Pharmaceutical Company Limited | AAV compositions |
| CA3138194A1 (en) | 2019-04-30 | 2020-11-05 | Bayer Healthcare Llc | Topical analgesic gel compositions |
| US12097186B2 (en) | 2019-04-30 | 2024-09-24 | Bayer Healthcare Llc | Topical analgesic compositions |
| CA3138193A1 (en) * | 2019-04-30 | 2020-11-05 | Bayer Healthcare Llc | Topical analgesic spray compositions |
| TWI845702B (zh) | 2019-06-11 | 2024-06-21 | 美商先進製藥公司 | 超氧化物歧化酶可溶纖維組成物 |
| ES2998817T3 (en) * | 2019-08-05 | 2025-02-21 | Cs Medica As | Topical formulations comprising cannabidiol, method of preparing the composition and use thereof |
| MX2022011400A (es) | 2020-03-17 | 2022-10-13 | Gruenenthal Gmbh | Aplicacion topica repetida de parche de capsaicina para usarse para tratar pacientes que no responden inicialmente al tratamiento. |
| KR20220164022A (ko) | 2020-04-03 | 2022-12-12 | 그뤼넨탈 게엠베하 | 캡사이신 패치의 반복된 국소 적용 요법 |
| CN113662739A (zh) * | 2021-08-20 | 2021-11-19 | 刘浩泉 | 一种冰敷贴及其制作方法 |
| CN118510495A (zh) * | 2022-01-07 | 2024-08-16 | 高露洁-棕榄公司 | 口腔凝胶组合物 |
| CN114652708B (zh) * | 2022-03-07 | 2024-04-26 | 宁波奇致年华医疗科技有限公司 | 一种治疗深部组织疼痛的组合物 |
| CN114917190A (zh) * | 2022-06-13 | 2022-08-19 | 郑州味千生物技术有限公司 | 用于掩盖苦味的产品 |
| WO2025129126A1 (en) * | 2023-12-14 | 2025-06-19 | Vm Therapeutics Llc | Topical formulations of calcium channel blockers |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486450B1 (en) | 1980-07-14 | 1998-07-28 | Joel E Bernstein | Method of treating psoriatic skin and composition |
| US4424205A (en) | 1982-03-18 | 1984-01-03 | The Procter & Gamble Company | Hydroxyphenylacetamides having analgesic and anti-irritant activity |
| US4681897A (en) * | 1984-01-16 | 1987-07-21 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
| US5145675A (en) | 1986-03-31 | 1992-09-08 | Advanced Polymer Systems, Inc. | Two step method for preparation of controlled release formulations |
| US5134166A (en) | 1988-12-02 | 1992-07-28 | Genderm Corporation | Method for treating nasal disorders and headaches |
| US4997853A (en) | 1988-12-02 | 1991-03-05 | Galenpharma, Inc. | Method and compositions utilizing capsaicin as an external analgesic |
| US5135747A (en) * | 1991-05-17 | 1992-08-04 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Deodorant/antiperspirant products with fragrance and encapsulated odor counteractant |
| US5178879A (en) | 1992-04-17 | 1993-01-12 | Michael Adekunle | Capsaicin gel |
| US5910512A (en) | 1994-04-18 | 1999-06-08 | Healthline Laboratories, Inc. | Topical analgesic using water soluble capsaicin |
| US5560910A (en) | 1994-08-26 | 1996-10-01 | Crandall; Wilson T. | Topical anti-inflammatory composition and method |
| US5665378A (en) * | 1994-09-30 | 1997-09-09 | Davis; Roosevelt | Transdermal therapeutic formulation |
| US6239180B1 (en) | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
| ATE219674T1 (de) | 1997-03-13 | 2002-07-15 | James N Campbell | Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika |
| JP3211027B2 (ja) | 1998-11-13 | 2001-09-25 | 丸石製薬株式会社 | カプサイシン含有外用剤 |
| US6573302B1 (en) | 1999-09-29 | 2003-06-03 | Medical Merchandising, Inc. | Cream utilizing capsaicin |
| US6348501B1 (en) | 1999-09-29 | 2002-02-19 | Medical Merchandising, Inc. | Lotion compositions utilizing capsaicin |
| JP3989188B2 (ja) * | 2001-04-27 | 2007-10-10 | クリストファー・エム・キム | 蜂針を用いない蜂毒療法 |
| US20040159575A1 (en) * | 2001-12-26 | 2004-08-19 | Jutaro Shudo | Access resistant envelope |
| US7943166B2 (en) | 2003-04-10 | 2011-05-17 | Neurogesx, Inc. | Methods and compositions for administration of TRPV1 agonists |
| JP5148271B2 (ja) * | 2004-06-02 | 2013-02-20 | ニューロジズエックス，インコーポレーテッド | 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物 |
| EA200701131A1 (ru) * | 2004-11-24 | 2007-12-28 | Алгоркс Фармасьютикалз, Инк. | Гелеобразная препаративная форма капсаициноида и способы её применения |
| EP1865941B8 (en) | 2005-04-01 | 2010-12-22 | Neurogesx, Inc. | Oils of capsaicinoids and methods of making and using the same |
| BRPI0610333A2 (pt) | 2005-04-25 | 2010-06-15 | Neurogesx, Inc | compostos agonistas de trpv1 e métodos de fazer e usar os mesmos |
| US7282224B1 (en) | 2006-06-09 | 2007-10-16 | Guthy-Renker Corporation | Pain relief composition |
| US7943666B2 (en) | 2006-07-24 | 2011-05-17 | Trinity Laboratories, Inc. | Esters of capsaicin for treating pain |
| CA2700159A1 (en) * | 2007-10-11 | 2009-04-16 | Mcneil-Ppc, Inc. | Improved topical pain relief product |
| US8637569B2 (en) | 2009-10-22 | 2014-01-28 | Api Genesis, Llc | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| EP3388057B1 (en) * | 2011-09-09 | 2022-03-09 | Propella Therapeutics, Inc. | A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof |
-
2012
- 2012-09-10 EP EP18161847.1A patent/EP3388057B1/en not_active Not-in-force
- 2012-09-10 EP EP12766516.4A patent/EP2753319B1/en not_active Not-in-force
- 2012-09-10 WO PCT/US2012/054511 patent/WO2013036961A1/en not_active Ceased
- 2012-09-10 MX MX2014002718A patent/MX347902B/es active IP Right Grant
- 2012-09-10 CN CN201280055002.XA patent/CN104010635A/zh active Pending
- 2012-09-10 KR KR1020147008331A patent/KR101769010B1/ko not_active Expired - Fee Related
- 2012-09-10 US US13/609,100 patent/US8889659B2/en not_active Expired - Fee Related
- 2012-09-10 BR BR112014005358A patent/BR112014005358A8/pt not_active Application Discontinuation
- 2012-09-10 JP JP2014529957A patent/JP6228540B2/ja not_active Expired - Fee Related
- 2012-09-10 CA CA2854206A patent/CA2854206C/en not_active Expired - Fee Related
-
2013
- 2013-03-12 US US13/797,494 patent/US8802736B2/en active Active
-
2014
- 2014-09-10 US US14/482,930 patent/US10821088B2/en active Active
-
2018
- 2018-05-07 US US15/972,625 patent/US20180250246A1/en not_active Abandoned
-
2020
- 2020-10-12 US US16/949,046 patent/US20210100759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2854206C (en) | 2018-04-10 |
| CA2854206A1 (en) | 2013-03-14 |
| US20130252925A1 (en) | 2013-09-26 |
| US20160106690A1 (en) | 2016-04-21 |
| US20130157985A1 (en) | 2013-06-20 |
| MX347902B (es) | 2017-05-18 |
| US20180250246A1 (en) | 2018-09-06 |
| KR101769010B1 (ko) | 2017-08-17 |
| US8889659B2 (en) | 2014-11-18 |
| WO2013036961A1 (en) | 2013-03-14 |
| CN104010635A (zh) | 2014-08-27 |
| MX2014002718A (es) | 2014-08-27 |
| JP6228540B2 (ja) | 2017-11-08 |
| EP2753319B1 (en) | 2018-04-11 |
| US8802736B2 (en) | 2014-08-12 |
| JP2014527964A (ja) | 2014-10-23 |
| EP3388057A1 (en) | 2018-10-17 |
| US10821088B2 (en) | 2020-11-03 |
| EP3388057B1 (en) | 2022-03-09 |
| KR20140062094A (ko) | 2014-05-22 |
| US20210100759A1 (en) | 2021-04-08 |
| BR112014005358A2 (pt) | 2017-03-28 |
| EP2753319A1 (en) | 2014-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014005358A8 (pt) | Composições compreendendo agonista seletivo de trpv1 e seus usos | |
| BR112016023815A2 (pt) | composições tópicas para o alívio da dor, produção e uso | |
| GT201500294A (es) | Compuestos de biaril-amida como inhibidores de cinasa | |
| NI201300073A (es) | Compuestos y composiciones como inhibidores de la trk | |
| PH12013502261A1 (en) | Partially saturated tricyclic compounds and methods of making and using same | |
| MX2020009780A (es) | Compuestos de inhibidor de autotaxina. | |
| BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
| IN2014DN09434A (https=) | ||
| MX2015005947A (es) | Formas de dosificacion de ruxolitinib de liberacion sostenida. | |
| CO7111303A2 (es) | Compuestos de microarn y métodos de modulación de la actividad de mir-21 | |
| MX2014008705A (es) | Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos. | |
| MX374452B (es) | Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades. | |
| UY32937A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119 | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
| PH12016500863A1 (en) | Tetracyclic autotaxin inhibitors | |
| UY35652A (es) | Bencil-1h-pirazolo[3,4-b]piridinas y su uso | |
| MX2016005446A (es) | Intervenciones a base de angiopoyetina para tratar la malaria cerebral. | |
| BR112013016789A2 (pt) | tratamento da dor associado ao deslocamento do endométrio basal | |
| MX2016006604A (es) | Derivados de piperidina con actividad multimodal contra el dolor. | |
| BR112016013116A8 (pt) | inibidores de trifluorometil pirazolil guanidina f1f0-atpase, seus usos, e composições farmacêuticas | |
| BR112015010225A2 (pt) | compostos tricíclicos e seus métodos de produção e utilização | |
| MX2020009966A (es) | Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina. | |
| BR112015010223A2 (pt) | compostos tricíclicos para o uso no tratamento e/ou controle de obesidade | |
| UA113065C2 (xx) | Композиція для нанесення на шкіру та її застосування |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: VIZURI HEALTH SCIENCES LLC (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: PROPELLA THERAPEUTICS, INC (US) |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |